Net Cash Provided by (Used in) Operating Activities |
-50.3K |
USD |
-235% |
Q1 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Financing Activities |
42K |
USD |
+114% |
Q1 2023 |
Q1 2023 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q4 2023 |
FY 2023 |
Common Stock, Shares, Issued |
51.4M |
shares |
0% |
Q4 2023 |
FY 2023 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2023 |
FY 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
4.6K |
USD |
|
Q1 2022 |
Q1 2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
28.4K |
USD |
+65.9% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Valuation Allowance |
1.51M |
USD |
+12.9% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
1.51M |
USD |
+12.9% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Authorized |
20M |
shares |
0% |
Q4 2023 |
FY 2023 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Additional Paid in Capital |
4.39M |
USD |
-29.5% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q4 2023 |
FY 2023 |
Interest Expense |
17.7K |
USD |
|
Q4 2023 |
Q4 2023 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2023 |
FY 2023 |